Furthermore, to assess the impact of OGF-Gem on the cell cycle progression of pancreatic cancer lines, samples underwent flow cytometry analysis to quantify the DNA levels corresponding to the G0/G1 phases, S phase, and G2/M phases (Figure 5C,D). The gene discussed is GEM; the disease is familial pancreatic carcinoma.